Organometallics
Article
[IHept·H][Pd(η3-cin)Cl2]. Following the general procedure from
IHept·HCl (50.0 mg, 0.08 mmol) and [Pd(η3-cin)(μ-Cl)]2(20.0 mg,
0.04 mmol), the product was obtained as a yellow powder in 96%
yield (67.0 mg). 1H NMR (400 MHz, CDCl3): δ (ppm) 8.51 (s, 2H,
CHImid), 7.95 (s, 1H, CNCHN), 7.60 (t, J = 7.8 Hz, 2H, CHAr), 7.49 (d,
J = 9.1 Hz, 2H, CHAr(cin)), 7.27−7.25 (m, 4H, CHAr), 7.21−7.19 (m,
3H, CHAr(cin)), 5.68 (br s, 1H, CH(cin)), 4.47 (br s, 1H, CH2(cin)), 3.88
(d, J = 6.0 Hz, 1H, CH2(cin)), 2.94 (d, J = 11.6 Hz, 1H, CH(cin)), 2.08
(m, 4H, CH(IHept)), 1.65−1.49 (m, 16H, CH2(IPent)), 1.34−1.25 (m,
4H, CH2(IHept)), 1.11−0.95 (m, 12H, CH2(IHept)), 0.89−0.81 (m, 24H,
CH3(IHept)). 13C{1H} NMR (100 MHz, CDCl3): δ (ppm) 143.1
(CAr), 134.2 (CHNCN), 132.0 (CHAr + CAr), 129.3 (CHimid), 128.6
(CHcin), 128.0 (CHcin), 125.3 (CHAr), 105.1 (CHcin), 68.9 (CHcin),
58.1 (CH2(cin)), 40.5 (CH(IHept)), 39.5 (CH2(IHept)), 38.3 (CH2(IHept)),
21.4 (CH2(IHept)), 21.0 (CH2(IHept)), 14.5 (CH3(IHept)), 14.2
(CH3(IHept)). Anal. Calcd for C52H78Cl2N2Pd: C, 68.75; H, 8.65; N,
3.08. Found: C, 68.75; H, 9.03; N, 2.96.
C
NCHN), 7.30−7.27 (m, 16H, CHAr), 7.16−7.10 (m, 16H, CHAr),
6.79−6.77 (m, 12H, CHAr), 5.43 (s, 6HIPr*,), 5.04 (br s. 1H, CHcrotyl),
3.71 (m, 2H, CH2(crotyl)), 2.56 (br s, 1H, CHcrotyl), 2.14 (s, 6H,
CH3(IPr*)), 1.29 (d, J = 5.6 Hz, 3H, CH3(crotyl)). 13C{1H} NMR (100
MHz, CDCl3): δ (ppm) 142.6 (CAr), 142.2 (CHNCN), 141.4 (CAr),
141.0 (CAr), 130.9 (CAr), 130.3 (CHAr), 129.2 (CHAr), 128.6 (CHAr),
128.5 (CHAr), 126.9 (CHAr), 126.7 (CHAr), 110.3 (CHimid), 79.6
(CHcrotyl), 57.3.0 (CHcrotyl), 51.1 (CH2(crotyl)), 21.8 (CH3(IPr*)), 18.1
(CH3(crotyl)). Anal. Calcd for C73H64Cl2N2Pd: C, 76.47; H, 5.63; N,
2.44. Found: C, 76.23; H, 5.49; N, 2.42.
[IPr*·H][Pd(η3-2-Me-allyl)Cl2]. Following the general procedure
from IPr*·HCl (50.0 mg, 0.05 mmol) and [Pd(η3-2-Me-allyl)(μ-
Cl)]2(10.3 mg, 0.03 mmol), the product was obtained as a yellow
1
powder in 99% yield (61.0 mg). H NMR (400 MHz, CDCl3): δ
(ppm) 11.89 (s, 1H, CNCHN), 7.29−7.03 (m, 32H, CHAr), 6.77−6.76
(m, 8H, CHAr), 6.71 (s, 4H, CHAr), 5.44 (s, 4H, CH(IPr*)), 5.37 (s,
2H, CHImid), 3.85 (br s, 2H, CH2(allyl)), 2.81 (br s, 1H, CHallyl), 2.53
(br s, 1H, CHallyl), 2.16 (s, 6H, CH3(IPr*)), 2.08 (br s, 3H, CH3(allyl)).
13C{1H} NMR (100 MHz, CDCl3): δ (ppm) 142.9 (CAr), 142.3
(CNCN), 141.9 (CAr), 141.1 (CAr), 140.7 (CAr), 131.1 (CHAr), 130.5
(CHAr), 129.4 (CHAr), 128.7 (CHAr), 128.2 (CHAr), 126.9 (CHAr),
126.8 (CHAr), 123.3 (CHimid), 105.9 (CHallyl), 60.5 (CHallyl), 59.5
(CHallyl), 51.3 (CH(IPr*)), 22.0 (CH3(IPr*)), 14.3 (CH3(allyl)). Anal.
Calcd for C73H64Cl2N2Pd: C, 76.47; H, 5.63; N, 2.44. Found: C,
76.32; H, 5.54; N, 2.42.
[INon·H][Pd(η3-cin)Cl2]. Following the general procedure from
INon·HCl (50.0 mg, 0.06 mmol) and [Pd(η3-cin)(μ-Cl)]2(17.0 mg,
0.03 mmol), the product was obtained as a yellow powder in 99%
1
yield (70.0 mg). H NMR (400 MHz, CDCl3): δ (ppm) = 8.45 (s,
2H, CHImid), 7.94 (s, 1H, CNCHN), 7.61 (t, J = 7.8 Hz, 2H, CHAr),
7.47 (d, J = 7.6 Hz, 2H, CHAr(cin)), 7.27 (d, J = 7.9 Hz, 4H, CHAr),
7.20 (d, J = 7.2 Hz, 3H, CHAr(cin)), 5.65 (br s, 1H, CH(cin)), 4.46 (br s,
1H, CH(cin)), 3.84 (br s, 1H, CH(cin)), 2.88 (br s, 1H, CH(cin)), 2.03
(m, 4H, CH(INon)), 1.67−1.52 (m, 16H, CH2(INon)), 1.28 (m, 20H,
CH2(INon)), 1.10−0.91 (m, 12H, CH2(INon)), 0.87 (t, J = 7.1 Hz, 12H,
CH3(INon)), 0.79 (t, J = 7.3 Hz, 12H, CH3(INon)). 13C{1H} NMR (100
MHz, CDCl3): δ (ppm) 143.1 (CAr), 134.3 (CHNCN), 132.2 (CHAr),
132.0 (CAr), 129.1 (CHimid), 128.6 (CHcin), 128.0 (CHcin), 125.4
(CHAr), 105.2 (CHcin), 68.9 (CHcin), 58.0 (CH2(cin)), 40.7 (CHcin),
37.0 (CH2(INon)), 35.6 (CH2(INon)), 30.2 (CH2(INon)), 30.0
(CH2(INon)), 23.1 (CH2(INon)), 22.8 (CH2(INon)), 14.1 (CH3(INon)),
13.9 (CH3(INon)). Anal. Calcd for C60H94Cl2N2Pd: C, 70.60; H, 9.28;
N, 2.74. Found: C, 70.42; H, 9.48; N, 2.81.
[IPr*·H][Pd(IndtBu)Cl2]. Following the general procedure from IPr*·
HCl (50.0 mg, 0.05 mmol) and [Pd(IndtBu)(μ-Cl)]2 (16.3 mg, 0.03
mmol), the product was obtained as a brown powder in 99% yield
(67.0 mg). 1H NMR (400 MHz, CDCl3): δ (ppm) 12.02 (s,
1H,CNCHN), 7.26−7.09 (m, 34H, CHAr), 6.91−6.75 (m, 15H, 10
CHAr+ 5 CHInd), 5.53 (m, 1H, CHInd), 5.42 (s, 2H, CHImid), 5.38 (s,
4, CH(IPr*)) 2.16 (s, 6H, CH3(IPr*)), 1.39−1.27 (m, 9H, CH3(Ind)).
13C{1H} NMR (100 MHz, CDCl3): δ (ppm) = 142.0 (CAr), 142.3
(CHNCN), 142.1 (CAr), 141.1 (CAr), 140.6 (CAr), 131.1 (CHAr), 130.4
(CHAr), 129.4 (CHAr), 128.6 (CHAr), 127.6 (CHInd), 127.3 (CHInd),
126.9 (CHAr), 126.8 (CHAr), 125.4 (CHInd), 123.2 (CHimid), 120.2
(CHInd), 118.8 (CHInd), 118.7 (CHInd), 107.6 (CHInd), 73.4 (CHInd),
51.2 (CH2), 34.3 (CH(Ind)), 29.0 (CH3(Ind)), 28.8 (CH3(Ind)), 22.0
(CH3(IPr*)). Anal. Calcd for C82H72Cl2N2Pd: C, 77.99; H, 5.75; N,
2.22. Found: C, 77.86; H, 5.60; N, 2.42.
General Procedure for the Buchwald−Hartwig Reactions. A
vial was charged with [IPr*·H][Pd(η3-cin)Cl2] (1.2 mg, 0.2 mol %),
KOtBu (62 mg, 0.55 mmol), CPME (1 mL), and a magnetic stir bar
and sealed with a screw cap. The mixture was stirred at 60 °C for 1 h.
The vial was removed from the heating block, and the corresponding
solution of aniline and aryl chloride in CPME (1 mL) was added. The
reaction was stirred (910 rpm) for 2 h at 80 °C. After this time, the
crude mixture was purified by filtration through silica gel and the
product isolated by removal of volatiles under reduced pressure.
General Procedure for the α-Arylation of Ketones. A vial was
charged with [IPr*·H][Pd(η3-cin)Cl2] (1.2 mg, 0.2 mol %), NaOtBu
(53 mg, 0.55 mmol), CPME (1 mL), and a magnetic stir bar and
sealed with a screw cap. The mixture was stirred at 60 °C for 1 h. The
vial was removed from the heating block, and the corresponding
solution of aryl ketone and aryl chloride in CPME (1 mL) was added.
The reaction was stirred (910 rpm) for 2 h at 80 °C. Volatiles were
removed under reduced pressure, and the crude product was purified
using flash chromatography (5/95 ethyl acetate/petroleum ether).
[Pr*OMe·H][Pd(η3-cin)Cl2]. Following the general procedure from
IPr*OMe·HCl (50.0 mg, 0.05 mmol) and [Pd(η3-cin)(μ-Cl)]2(13.0
mg, 0.02 mmol), the product was obtained as a yellow powder in 99%
yield (63.0 mg). 1H NMR (400 MHz, CDCl3): δ (ppm) 12.29 (s, 1H,
CNCHN), 7.34−7.08 (m, 35H, CHAr), 6.79 (d, J = 7.2 Hz, 10H, CHAr),
6.46 (s, 4H, CHAr), 5.80−5.60 (br m, 1H, CH(cin)), 5.45 (s, 4H,
CH(IPr*OMe)), 5.23 (s, 2H, CHImid), 3.85 (br s, 1H, CH(cin)), 3.76 (br
s, 1H, CH(cin)), 3.51 (s, 6H, CH3(IPr*OMe)), 2.87 (br s, 1H, CH(cin)).
13C{1H} NMR (100 MHz, CDCl3): δ (ppm) 160.5 (CAr), 143.2
(CHNCN), 143.0 (CAr), 142.7 (CAr), 142.2 (CAr), 130.4 (CHAr), 129.3
(CHAr), 128.6 (CHAr), 128.6 (CHAr), 128.2 (CHAr), 127.0 (CHAr),
126.9 (CHAr), 125.8 (CH), 123.1 (CHimid), 115.7 (CHAr), 105.7
(CHcin), 69.0 (CHcin), 55.2 (OCH3(IPr*OMe)), 51.5 (CH(IPr*OMe)).
Anal. Calcd for C78H66Cl2N2O2Pd: C, 75.51; H, 5.36; N, 2.26. Found:
C, 75.33; H, 5.64; N, 2.32.
[IPentCl·H][Pd(η3-cin)Cl2]. Following the general procedure from
IPentCl·HCl (50.0 mg, 0.08 mmol) and [Pd(η3-cin)(μ-Cl)]2(21.0 mg,
0.04 mmol), the product was obtained as a yellow powder in 99%
yield (71.0 mg). 1H NMR (400 MHz, CDCl3): δ (ppm) 12.41 (s, 1H,
CNCHN), 7.60 (t, J = 7.7 Hz, 2H, CHAr), 7.48 (d, J = 7.3 Hz, 2H,
CHAr(cin)), 7.29 (d, J = 7.7 Hz, 4H), 7.24−7.23 (m, 3H, CHAr(cin)),
5.74 (br s, 1H, CH(cin)), 4.56 (br s, 1H, CH2(cin)), 3.92 (br s, 1H,
CH2(cin)), 2.97 (br s, 1H, CH(cin)), 1.96−1.95 (m, 4H, CH(IPentCl)),
1.86−1.78 (m, 8H, CH2(IPentCl)), 1.69−1.63 (m, 8H, CH2(IPentCl)),
0.89−0.84 (m, 24H, CH3(IPentCl)). 13C{1H} NMR (100 MHz,
CDCl3): δ (ppm) 143.4 (CAr), 142.8 (CClimid), 137.3 (CHNCN),
132.2 (CHAr), 129.6 (CHAr), 128.1 (CHAr), 126.1 (CHAr), 121.1
(CAr), 105.9 (CHcin), 81.9 (CHcin), 59.2 (CH2(cin)), 43.4 (CH(IPentCl)),
29.3 (CH2(IPentCl)), 27.2 (CH2(IPentCl)), 12.4 (CH3(IPentCl)), 11.9
(CH3(IPentCl)). Anal. Calcd for C44H60Cl4N2Pd: C, 61.08; H, 6.99;
N, 3.24. Found: C, 60.90; H, 6.78; N, 3.14.
ASSOCIATED CONTENT
■
S
* Supporting Information
The Supporting Information is available free of charge on the
[IPr*·H][Pd(η3-crotyl)Cl2]. Following the general procedure from
IPr*·HCl (50.0 mg, 0.05 mmol) and [Pd(η3-crotyl)(μ-Cl)]2(10.3 mg,
0.03 mmol), the product was obtained as a yellow powder in 99%
yield (60.0 mg). 1H NMR (400 MHz, CDCl3): δ (ppm) 11.60 (s, 1H,
Materials, methods, optimization data, detailed synthetic
procedures, and spectroscopic data and spectra (PDF)
D
Organometallics XXXX, XXX, XXX−XXX